Nanobots Therapeutics-preview

Nanobotstx

Nanobots Therapeutics

Private

BarcelonaHealthcare & Life Scienceshttps://www.nanobotstx.com/

Last Round

Seed

Dec 5, 2024

Est. Valuation

$7.81M

Total Funding Raised

$2.5M

Company Overview

Nanobots Therapeutics is a biotechnology company developing a nanorobot-based drug delivery platform, MotionTx, to deliver treatments directly to target tissues, with an initial focus on bladder cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

drug delivery platformself-propelled nanorobotsnanomedicinemedical nanobotstargeted drug deliverybladder cancer treatmentnon-muscle invasive bladder cancerNMIBConcologysolid tumorsbiotechnology platformpharma partnershipspreclinical biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanobots Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nanobots Therapeutics Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Dec 5, 2024
Pre Seed	Sep 22, 2023

View all Funding Rounds

Key People

Founding team and executive leadership

Andres G. Fernandez

Chief Development Officer (CDO), Member Of The Management Board, Co-Founder - Drug Development Advisor

Founding Team

Samuel Sánchez Ordóñez

Founder, Interim CEO And CSO, Chief Scientific Officer

Founding Team

Marta Soler Grima

COO

Executive Team

Nanobots Therapeutics Investors

Notable investors and investment history

Investor	Rounds
ACCIÓ - Agency for Business Competitiveness	Pre Seed, Seed
Prous Institute for Biomedical Research	Pre Seed, Seed
BStartup Health	Seed, Pre Seed
Esade Business Angels Network	Pre Seed, Seed

View all Investors

Nanobots Therapeutics Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Nanobots Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanobots Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona

Employee Range13

Year Founded2023

Last FundingDec 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.